H30.81
Harada's disease
Clinical Classification Guidelines
Medical Intelligence & Overview
Harada's disease, also known as Vogt-Koyanagi-Harada (VKH) syndrome, is a rare, autoimmune condition that affects the eyes, skin, and other organs. It primarily involves inflammation of the uvea (the middle layer of the eye), leading to vision problems and other systemic symptoms. Though uncommon, this syndrome can significantly impact a person's quality of life if not diagnosed and managed appropriately.
Causes & Symptoms
Clinical Causes: Autoimmune response where the body's immune system mistakenly attacks its own melanocyte-containing tissues Genetic predisposition, with certain HLA (human leukocyte antigen) types possibly increasing risk Environmental factors, such as exposure to certain infections or environmental triggers, may play a role
Key Symptoms: Blurred or reduced vision Visual disturbances, including flashes or floaters Redness and pain in the eyes Sensitivity to light (photophobia) Loss of pigment in the skin or hair (depigmentation), particularly of the eyelashes, eyebrows, or scalp Tinnitus or loss of hearing Headaches and neurological symptoms in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Harada's disease involves a combination of clinical evaluation and diagnostic tests. An ophthalmologist may perform a detailed eye examination, including slit-lamp examination, fluorescein angiography, and optical coherence tomography (OCT). Additional assessments may include neurological evaluation and imaging studies to rule out other causes of inflammation. Blood tests and HLA typing can support the diagnosis by identifying autoimmune markers or genetic susceptibility factors.
Treatment Protocols: Treatment typically involves corticosteroids to decrease inflammation and suppress the immune response. Immunosuppressive agents such as cyclosporine, azathioprine, or mycophenolate mofetil may be used in more severe or persistent cases. Supportive care can include eye drops or other therapies to manage symptoms and prevent complications like scarring or vision loss. Early diagnosis and prompt treatment are vital to improving outcomes and minimizing long-term ocular damage.
Clinical Advice & FAQs
Billing Guidance
Is H30.81 a billable ICD-10 code?
Yes, H30.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H30.81?
Clinical documentation must specify the nature of Harada's disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference